Wells Fargo Maintains Overweight on Abbott Laboratories, Raises Price Target to $120

Benzinga · 1d ago
Wells Fargo analyst Larry Biegelsen maintains Abbott Laboratories (NYSE:ABT) with a Overweight and raises the price target from $119 to $120.